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DCs are BM-derived cells present in lymphoid 
and nearly all nonlymphoid tissues. Their prin-
cipal function is the induction and control of 
immunity (Steinman and Banchereau, 2007). 
Recent studies in mice have also highlighted 
the role of DCs in maintaining tolerance. Con-
stitutive depletion of DCs results in autoimmu-
nity (Ohnmacht et al., 2009), and there appears 
to be a direct homeostatic balance between the 
frequency of DCs and regulatory T (T reg) cells 
(Darrasse-Jèze et al., 2009).
Significant progress has been made in un-
derstanding the early events in DC ontogeny. 
Studies of hematopoiesis have previously docu-
mented that DCs can arise from both myeloid 
and lymphoid progenitors (Merad and Manz, 
2009), but the myeloid origin of DCs has been 
the focus of much attention in recent years, with 
elucidation of the common origin but subsequent 
separation of monocyte and DC lineages in mice 
(Liu et al., 2009; Geissmann et al., 2010).
Adoptive transfer and KO experiments in-
dicate that LN DCs and major subsets of mi-
gratory tissue DCs are derived from committed 
precursors, with the important exception of 
Langerhans cells (LCs), which are self-renewing 
(Merad and Manz, 2009). Monocytes contrib-
ute to inflammatory DCs in many sites, replace 
LCs after injury, and are also regarded as the 
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Congenital or acquired cellular deficiencies in humans have the potential to reveal much 
about normal hematopoiesis and immune function. We show that a recently described 
syndrome of monocytopenia, B and NK lymphoid deficiency additionally includes the near 
absence of dendritic cells. Four subjects showed severe depletion of the peripheral blood 
HLA-DR+ lineage- compartment, with virtually no CD123+ or CD11c+ dendritic cells (DCs) 
and very few CD14+ or CD16+ monocytes. The only remaining HLA-DR+ lineage2 cells were 
circulating CD34+ progenitor cells. Dermal CD14+ and CD1a+ DC were also absent, consis-
tent with their dependence on blood-derived precursors. In contrast, epidermal Langerhans 
cells and tissue macrophages were largely preserved. Combined loss of peripheral DCs, 
monocytes, and B and NK lymphocytes was mirrored in the bone marrow by complete 
absence of multilymphoid progenitors and depletion of granulocyte-macrophage progeni-
tors. Depletion of the HLA-DR+ peripheral blood compartment was associated with elevated 
serum fms-like tyrosine kinase ligand and reduced circulating CD4+CD25hiFoxP3+ T cells, 
supporting a role for DC in T reg cell homeostasis.
© 2011 Bigley et al.  This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
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Automated peripheral blood counts indicated monocyte 
deficiency and variable lymphopenia, without significant gran-
ulocytopenia, anemia, or thrombocytopenia (Table S2). His-
torical blood counts demonstrated that monocytopenia had 
existed for at least 3 yr in subject 1, >4 yr in subject 2, at least 
12 yr in subject 3, and a minimum of 10 yr in subject 4 (un-
published data).
We hypothesized that an associated deficit of DCs could 
contribute to the marked immunodeficiency of this syndrome,   
as the induction of immunity by DCs is assumed to be as criti-
cal as monocyte-macrophage effector function in maintaining 
immunocompetence. Furthermore, murine studies have ar-
gued persuasively that monocytes and DCs arise via separate 
lineages from a common precursor (Merad and Manz, 2009; 
Geissmann et al., 2010). This pathway has not been mapped in 
humans and we reasoned that more detailed analysis of mono-
cyte and DC lineages in this syndrome might be informative.
Peripheral blood flow cytometry showed severe depletion 
of the HLA-DR+ lineage2 compartment (Fig. 1). Quantita-
tively, CD14+ monocytes were as low as 0.1% and no greater 
than 5.5% of median normal values. CD16+ monocytes   
were more variable, ranging from 0.2 to 24.2% of normal 
median values. CD123+ plasmacytoid DCs and CD11c+ my-
eloid DCs were undetectable in all subjects. CD11c+ cells 
may normally be subdivided into CD141+ and CD1c+ frac-
tions, but neither was detectable (unpublished data). The only 
remaining HLA-DR+ lineage2 cells were CD34+ progenitor 
cells, which were relatively expanded. As described previously, 
CD19+ B cells and CD56+ NK cells were depleted, but CD3+ 
T cells were in the normal range. Hereafter, we refer to this 
combined deficit of DC, monocyte, B and NK lymphoid cells 
as DCML deficiency.
Functional defects indicating susceptibility  
to mycobacterial disease
To test the functional consequence of these cellular deficiencies, 
we analyzed the integrity of the IL-12/IFN- axis in vitro   
by measuring IL-12 and IFN- production in response to 
LPS,  complemented  in  turn  with  IFN-  or  IL-12. There   
was severe impairment of IL-12 and a reduction of IFN- 
production with LPS challenge, implying disruption of the 
IL-12/IFN- axis (Fig. 2).
Defects of IL-12/IFN- in these assays correlate well 
with in vivo susceptibility to mycobacterial infection and 
have been confirmed repeatedly in several genetic disor-
ders affecting cytokine production or signal transduction 
in  the  IL-12  or  IFN-  pathways,  collectively  known  as 
Mendelian susceptibility to mycobacterial disease (MSMD; 
Casanova and Abel, 2007). One feature of DCML defi-
ciency  that  distinguishes  it  from  classical  MSMD  is  the   
impaired production of the monokines TNF and IL-6 in 
response to LPS alone. We surmise that this directly reflects 
monocyte  depletion,  which  does  not  occur  in  classical 
MSMD.  Residual  production  of TNF  and  IL-6  in  this 
whole-blood assay is most likely caused by direct activation 
of neutrophils by LPS.
precursors of tissue macrophages (Ginhoux et al., 2006;   
Geissmann et al., 2010). Several genes have been shown to 
control DC differentiation in mice, many of which also influ-
ence the differentiation of other myeloid or lymphoid lin-
eages (Merad and Manz, 2009; Geissmann et al., 2010).
In humans, it has not been possible to probe the distal   
relationships between monocytes and DCs or to prove the 
independence of LCs from BM-derived precursors in the 
steady state. Hematopoietic stem cell transplantation allows   
some inferences to be drawn from kinetic differences in the 
replacement of tissue DCs, LCs, and macrophages (Collin et al., 
2006; Haniffa et al., 2009), but these data fall significantly 
short of the steady-state models that have been so effective in 
mice. New human models, in which there is spontaneous de-
ficiency of blood DCs or monocytes, are required to test the 
relationships between DC precursors and their progeny.
To shed light on these issues, we searched for human sub-
jects with DC deficiency. This was found in association with 
a combined monocyte, B and NK lymphoid defect and clini-
cal features including disseminated nontuberculous myco-
bacterial infection, papilloma virus infection, and pulmonary 
alveolar proteinosis. The clinical manifestations of this novel 
syndrome have recently been characterized in a seminal study 
(Vinh et al., 2010). In this report, we demonstrate an accom-
panying profound deficit of blood and tissue DCs and explore 
the associated ontological and immunoregulatory features of 
the syndrome.
RESULTS AND DISCUSSION
Combined DC, monocyte, B and NK lymphoid deficiency  
in humans
The syndrome of autosomal dominant and sporadic monocy-
topenia has recently been described in a study of 18 individuals 
(Vinh et al., 2010). The primary features include immunodefi-
ciency with increased susceptibility to mycobacterial infection, 
papilloma virus infection, and pulmonary alveolar proteinosis. 
10 out of 18 patients developed hematological or other ma-
lignancies, and 4 had evidence of autoimmune phenomena.   
A genetic basis for this disorder is strongly implicated by an   
autosomal-dominant pattern of inheritance. Although hetero-
geneous clinical features are seen, these often arise even within 
one pedigree in genetic immunodeficiency disorders, and do 
not exclude a single gene etiology (Casanova and Abel, 2007).
We identified four subjects with this syndrome. Subject 1 
presented at the age of 12 with disseminated bacillus Calmette-
Guerin infection after routine vaccination and is included in 
the published case series (Vinh et al., 2010). Subject 2 was di-
agnosed at the age of 27 with spontaneous Mycobacterium  
kansasii infection. Subject 3 developed respiratory failure at 
age 21 caused by pulmonary alveolar proteinosis. Subject 4 
presented with recurrent erythema nodosum and papilloma 
virus infection at age 23. Subjects 1, 2, and 4 had no affected 
relatives and are likely sporadic cases, whereas subject 3 re-
ported two generations of ancestors dying of early respiratory 
death or malignancy, in keeping with autosomal dominant 
inheritance. Full clinical details are given in Table S1.JEM VOL. 208, February 14, 2011  229
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Deficiency of peripheral migratory myeloid DCs with sparing 
of LCs and tissue macrophages
Having observed almost complete loss of DCs and mono-
cytes from the blood, we took macroscopically healthy skin to 
determine if tissue DCs were similarly affected, using a flow 
cytometric assay as previously described (Haniffa et al., 2009). 
The CD45+ HLA-DR+ non-autofluorescent compartment, 
which typically contains dermal DCs in healthy individuals, 
was depleted (Fig. 3 A, gate 1), and CD14+ and CD1a+ DCs 
were virtually absent (Fig. 3 B). This suggests that myeloid   
tissue DCs share a common origin with circulating HLA-DR+ 
lineage2 cells, although we are unable to dissect the relation-
ship between tissue DCs and either blood DCs or monocytes 
because both were depleted.
CD1ahigh langerin+ cells, which represent migratory LCs 
passing through the dermis (Fig. 3 A, gate 3; Angel et al., 
2006), remained detectable. CD45+ HLA-DR+ autofluo-
rescent dermal macrophages were also present (Fig. 3 A, 
gate 2), but were variably depleted compared with normal 
(Fig. 3 B). Examination of intact epidermal sheets by whole-
mount microscopy confirmed the presence of an intact LC 
network in three of four subjects (Fig. 3, C and D). LC 
density was reduced in two subjects, with patchy disruption 
of the network in one (subject 2). This could not be attrib-
uted to a decreased proliferative index because the proportion 
Figure 1.  Deficiency of peripheral blood DCs, monocytes, and lymphoid cells. Flow cytometry of PBMCs and proportion of lymphoid, monocyte, 
and DC fractions in the subjects relative to controls. Plots show equivalent numbers of total cells analyzed (75,000 for DCs; 65,000 for lymphocytes). Error 
bars indicate mean ± SD from a population of normal individuals (n = 11 for lymphoid cells; n = 28 for HLA-DR+ lineage2 cells). One of at least two inde-
pendent results is shown for subjects 1–4. (A) CD3+ T cells, CD19+ B cells, and CD56+ NK cells. (B) HLA-DR+ lineage2 (CD3/19/56) cells further divided into 
CD14+ and CD16+ monocyte fractions and double-negative CD142CD162 cells, which comprise CD34+ progenitor cells, CD123+ PDCs, and CD11c+ myeloid 
DC fractions. (C) Quantitative analysis of monocyte/DC fractions, expressed as percentage of mononuclear cells, and lymphoid cells, expressed as percent-
age of cells in the lymphoid SSC/FSC gate, compared with healthy controls.
Figure 2.  Dysfunction of the IL-12–IFN- axis. Cytokines released 
into the supernatant when whole blood was stimulated in vitro with LPS, 
IL-12, or IFN- as indicated. A paired “travel control” was run with each 
subject, and each subject was analyzed at least twice. The graph shows 
the mean ± SD for subjects (n = 4) compared with controls (n = 4) from 
one experiment. *, P < 0.05 compared with adjacent control (paired Stu-
dent’s t test).230 Human DC deficiency | Bigley et al.
We  were  initially  surprised  to  observe  dermal  macro-
phages in the near absence of monocytes. However, CD68+ 
tissue macrophages were also found in BM and alveolar spaces 
(Fig. S2) and inflammatory macrophages have been previ-
ously documented in this syndrome (Vinh et al., 2010). Simi-
lar to LCs, these populations of macrophages appear to persist 
independently of blood monocytes.
Historical blood counts show that monocytopenia had per-
sisted for more than a decade in at least two of the subjects.   
Either these surviving populations of macrophages have half-
lives of a decade or more, or are derived from nonmonocyte 
precursors. Recent evidence indicates that dermal and alveolar 
macrophages can indeed be extremely long-lived and might 
persist in the absence of circulating precursors (Murphy et al., 
2008; Haniffa et al., 2009). Although monocytes were severely 
depleted, the circulating CD34+ cell is a potential alternative pre-
cursor. Trafficking hematopoietic stem cells have been shown   
to  differentiate  directly  into  antigen-presenting  cells  in  the 
mouse (Massberg et al., 2007). The surprising demonstration of 
alveolar macrophages in lungs affected by pulmonary alveolar 
proteinosis strongly suggests that a qualitative rather than quan-
titative macrophage defect is responsible for this pathology.
of CD1a+ LCs coexpressing Ki-67 was the same or greater 
than controls (Fig. 3 E and Fig. S1 A). The preservation   
of dermal macrophages did not appear to reflect local pro-
liferation because no Ki-67+ S/G2/M phase cells are de-
tectable in this population (Fig. S1 B). Although we took 
care to biopsy macroscopically healthy skin, prior cutaneous 
inflammation or ultraviolet exposure may have contrib-
uted to lower LC density, particularly the patchy depletion 
seen in subject 2.
The survival of LCs in the absence of monocytes or blood 
DCs is predicted by murine experiments showing local self-
renewal (Merad and Manz, 2009). Although monocyte defi-
ciency was not absolute, subjects 1, 3, and 4 had very severe 
monocytopenia with as few as 0.1% CD14+ and 0.2% CD16+ 
monocytes, compared with healthy controls. Blood DCs were 
even  further  depleted.  In  contrast,  their  LC  networks  re-
mained intact and populated at 50–100% of normal density. 
These results therefore show the persistence of human LCs 
independent of blood monocytes and DCs. The complete ab-
sence of dermal DCs argues against the view that human LCs 
derive from dermal-based CD14+ precursors in the steady 
state (Larregina et al., 2001).
Figure 3.  Depletion of tissue DCs, but preservation of LCs and macrophages. (A) Analysis of dermal DC populations by flow cytometry of  
collagenase-digested dermis. Plots show equivalent number of total cells analyzed (40,000). Gated CD45+ HLA-DR+ cells normally comprise two fractions  
separable by autofluorescence (AF) and side scatter (SSC). AF2 SSClow cells (gate 1) contain CD14+ DCs, CD1a+ DCs, and occasional CD1ahigh langerin+ 
migrating LCs (gate 3); AF+ SSChigh cells are macrophages (gate 2). CD1ahigh cells express langerin (subject 1, inset). Subjects 1 and 3 were analyzed twice, 
independently; subjects 2 and 4 were analyzed once. (B) Dermal DCs, LCs, and macrophage counts relative to normal controls (n = 22; mean ± SD).  
(C) Whole-mount immunofluorescence staining for CD1a of epidermal sheets showing representative fields of each subject. (D) Total LC counts averaged 
from entire low-power image relative to controls (n = 12; mean ± SD). (E) Proportion of Ki-67+ LCs in whole-mount epidermal sheets relative to  
controls (n = 3).JEM VOL. 208, February 14, 2011  231
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The observation of spontaneous DC deficiency gave us a 
unique opportunity to examine human DC/Flt3L and DC/
T reg cell coregulation in vivo. The models developed in mice 
predict that DC deficiency should lead to elevated Flt3L in 
association with a loss of T reg cells. In subjects with DCML 
deficiency, we found massive elevation of Flt3L up to 100-
fold that of controls (Fig. 5 A). M-CSF was also elevated in 
Complete loss of the multilymphoid progenitor (MLP) with 
depletion of granulocyte macrophage progenitors in BM
DCML deficiency occurs in the context of normal erythroid, 
granulocyte, and platelet production, leading us to ask whether 
this disorder might be associated with a specific progenitor 
defect. It has previously been demonstrated that DC potential 
resides in both myeloid and lymphoid compartments in   
humans (Galy et al., 1995; Chicha et al., 2004). In particular, 
we were intrigued by the recent description in humans of 
MLP; cells capable of forming DCs, macrophages, and lym-
phoid cells but lacking erythroid, granulocyte, or megakaryo-
cyte potential (Doulatov et al., 2010). The combination of 
cellular deficiency in DCML suggested that this population 
might be specifically deleted.
BM of subjects 1, 3, and 4 was available for flow cy-
tometric  analysis. We  characterized  CD34+  progenitors,   
including  the  CD382CD902/loCD45RA+  MLP  and 
CD38+CD102CD45RA+ granulocyte macrophage progeni-
tor (GMP; Doulatov et al., 2010). In all subjects, routine   
histological, cytological, and cytogenetic examination of BM 
showed normal hematopoiesis (Table S1 and Fig. S3). Despite 
this, flow cytometry revealed a complete absence of MLP, 
with 72–95% depletion of GMP. An immediate progeny of 
the MLP, the more restricted CD38+ CD10+ B/NK precur-
sor, was also completely absent (Fig. 4).
This analysis proves that DCML deficiency arises as a re-
sult of a defect in the BM and identifies a deficiency of both 
the MLP and GMP. Although sufficient GMPs are preserved 
to maintain granulopoiesis, these progenitors appear unable to 
support monocyte and DC development. These findings sug-
gest that MLP at least contributes to the normal homeostasis 
of DCs and monocytes and are consistent with models of   
hematopoiesis in which DCs and monocytes may arise from 
both lymphoid (MLP) and myeloid (GMP) origins (Galy   
et al., 1995; Chicha et al., 2004; Doulatov et al., 2010).
DC deficiency is associated with elevated fms-like tyrosine 
kinase ligand
There are multiple lines of evidence that fms-like tyrosine   
kinase (Flt3) ligand (Flt3L) acts on both BM progenitors and 
peripheral DC precursors to maintain DC homeostasis and 
that numbers of DCs and level of Flt3L are inversely corre-
lated (McKenna et al., 2000; Tussiwand et al., 2005; Waskow   
et al., 2008; Hochweller et al., 2009). Furthermore, constitu-
tive depletion of DCs in mice via CD11c-DTA transgene is 
associated with approximately threefold elevation of Flt3L 
and a myeloproliferative syndrome (Birnberg et al., 2008).
The coregulation of DCs and T reg cells has been high-
lighted by several recent in vivo studies. Depletion of T reg 
cells increases DC proliferation by a Flt3L-dependent mecha-
nism (Kim et al., 2007; Liu et al., 2009). Conversely, maneu-
vers to increase or deplete DCs by manipulation of Flt3L 
concentration led to parallel changes in T reg cell frequency 
and protective or autoimmune sequelae (Birnberg et al., 2008; 
Swee et al., 2009). This has led to a model of coordinated 
DC/T reg cell homeostasis (Darrasse-Jèze et al., 2009).
Figure 4.  Depletion of specific compartments of CD34+ BM cells. 
Flow cytometric analysis of CD34+ progenitor compartments in BM  
according to a recent protocol (Doulatov et al., 2010). Control (performed 
7 times); subjects 1, 3, and 4, as indicated (performed twice). Total BM 
mononuclear cells are shown. The minimum number of CD34+ cells ana-
lyzed was 4,500. Numbers show the percentage of CD34+ cells in each 
gate. Gate 1 contains CD45+ cells; gate 2 contains CD34+ cells; gate 3 
contains committed CD38+ fraction; gate 4 contains a primitive CD382 
fraction. All definitions according to Doulatov et al., 2010. HSC, hemato-
poietic stem cell; MPP, multipotent progenitor; B/NK, committed B/NK 
precursor; CMP, common myeloid progenitor; MEP megakaryocyte/ 
erythroid progenitor. In this analysis, it was not possible to separate Flt-3+ 
CMP from Flt-32 MEP because Flt3 was not expressed by the subjects’ 
CD34+ cells; thus, CMP and MEP were combined.232 Human DC deficiency | Bigley et al.
The ratio of CD4+ to CD8+ T cells was not significantly 
perturbed, but we noted an increase in the proportion of acti-
vated CD56+ CD3+ T cells and CD25+ CD3+ T cells in the 
subjects (Fig. 5 E). A similar phenomenon has been observed 
when mice are rendered T reg cell deficient directly or via 
DC  depletion  (Kim  et  al.,  2007;  Birnberg  et  al.,  2008;   
Darrasse-Jèze et al., 2009; Ohnmacht et al., 2009). There was 
no significant association between T reg cell and B cell fre-
quency in healthy individuals (unpublished data). Intriguingly, 
approximately one quarter of patients with DCML deficiency, 
including subject 4, have autoimmune syndromes (Vinh et al., 
2010). T reg cell depletion as a consequence of DC deficiency 
may contribute to this phenomenon.
Finally, we considered whether the loss of NK cells might 
be related to lack of IL-15–bearing DCs, as recently described 
in mice (Guimond et al., 2010). In contrast to this model, in 
which there is diminished proliferation of mature NK cells, 
we have shown a severe deficit of NK precursors in BM, sug-
gesting a more proximal defect. In addition, there was no sig-
nificant relationship between the frequency of NK cells and 
HLA-DR+lineage2 peripheral blood DCs in healthy volun-
teers (unpublished data).
The genetic basis of DCML deficiency
The genetic basis of DCML deficiency remains unsolved.   
We have established that a BM defect is present with the ab-
sence of MLP and depletion of GMP. It is also known that the 
defect is expressed in the hematopoietic com-
partment  because  the  phenotypes  of  subjects   
1 and 3 were corrected by hematopoietic stem 
cell transplantation (Fig. S4).
Flt3, Flt3L, and several downstream signaling 
or transcription factors have been shown to be es-
sential for DC development in mice. Flt3 signal-
ing is critically dependent on STAT3 (Schiavoni 
et al., 2002), which in turn activates transcription 
of differentiation factors PU.1 and Flt3 itself;   
IRF8 and MCSF-R are also downstream targets   
(Laouar et al., 2003; Carotta et al., 2010).
Although  high  Flt3L  can  down-regulate 
Flt3 expression (Tussiwand et al., 2005) it was 
three of four subjects. In contrast, stem cell factor (SCF),   
another early acting hematopoietic growth factor, was not 
elevated (Fig. 5 A). We were also unable to detect surface 
Flt3/CD135  on  any  compartment  of  CD34+  stem  cells, 
whereas SCF-R/CD117 expression was preserved (Fig. 5 B). 
Down-regulation of Flt-3 by receptor internalization in the 
presence of high levels of ligand has previously been directly 
observed in mice (Tussiwand et al., 2005).
DC deficiency is associated with depletion of T reg cells
Working initially with 21 healthy volunteers, we were sur-
prised to find a significant positive correlation between the 
absolute frequency of HLA-DR+ lineage2 cells (DCs, mono-
cytes, and CD34+ cells) and CD4+CD25hiFoxP3+ T reg cells 
in peripheral blood. It appears that interindividual variation is 
sufficient to demonstrate this relationship in humans. As pre-
dicted, severe DC deficiency was associated with depletion   
of T reg cells (Fig. 5, C and D). Plotting the four subjects   
together with normal blood profiles increased the signifi-
cance of the relationship without changing the slope of the 
regression (Fig. 5 D). The subjects had a 53–88% reduction in 
T reg cell count compared with the normal median value of 
0.041 × 106 per ml.
Isolating specific DCs or HLA-DR+ populations did not 
increase the strength of the association with T reg cells. This is 
not unexpected, as the model argues that homeostatic prolif-
eration occurs in an MHC class II–dependent fashion.
Figure 5.  Elevation of Flt3L with T reg cell  
deficiency. (A) Serum Flt3L, M-CSF, and SCF concentra-
tions measured by ELISA. Each subject was analyzed 
once. (B) Expression of Flt-3/CD135 and SCF-R/CD117 on 
BM CD34+ cells of subjects 1 and 3 compared with 
healthy controls and isotype (filled histogram). Each sub-
ject was analyzed twice. (C) Representative example of  
T reg cell analysis from subject versus normal control. 
Number indicates absolute count ×106 /ml. (D) Absolute 
number of CD4+CD25hiFoxP3+ T reg cells compared with 
HLA-DR+ lineage2 (CD3, 19, 20, 56) cells in subjects 1–4, 
as indicated, and controls (n = 21). Each subject was 
analyzed once. (E) Proportion of CD56+ and CD25+ CD3+ 
T cells in subjects 1–4 as indicated relative to controls.JEM VOL. 208, February 14, 2011  233
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List Biochemicals). Supernatants were taken at 12 h (for TNF and IL-12 pro-
duction), 24 h (for IL-6 production), and 48 h (for IFN- production). Cyto-
kines were measured using standard ELISA according to the manufacturer’s 
recommendations (IFN-, TNF, IL-6, and IL-12; R&D Systems).
Flow cytometry. PBMCs, BM, and normal skin preparations, were stained 
in aliquots of 106 cells in 50 µl of buffer according to standard protocols. For 
subject skin biopsies, all available cells were prepared. Flow cytometry was 
performed on an LSRII cytometer (BD), and data was analyzed with FlowJo 
(Tree Star, Inc.). Viability was usually >95% by DAPI (Partec) or LIVE/
DEAD dead cell stain (Invitrogen) exclusion. The following antibodies were 
obtained from BD unless otherwise indicated: antigen fluorochrome (clone); 
CD1a FITC (NA1/34; Dako); CD1a APC (HI 149); CD3 FITC PE APC 
(UCHT1) PerCPCy5.5 (SK7); CD4 FITC (SK3); CD8 APCCy7 (SK1); 
CD10 APC (HI10a); CD11c APC V450 (B-ly6); CD14 PE PECy7 (M5E2) 
and QDOT605 (TuK4; Invitrogen); CD16 FITC PE PECy7 (3G8); CD19 
FITC PE PECy7 (SJ25C1); CD25 PE PECy7 (2A3); CD34 APC (8G12) and 
APCCy7 (581; BioLegend); CD38 PE-Cy7 (HB7); CD45 APCCy7 V450 
(2D1); CD45RA FITC (L48) PE (HI100); CD56 FITC PE (NCAM16.2); 
CD90 Qdot605 (5E10; eBioscience); CD123 PE (9F5); CD135 PE (4G8); 
HLA-DR  PerCP  Cy5.5  (L243);  and  Langerin  PE  (DCGM4;  Beckman 
Coulter). Intracellular staining with FoxP3 APC (PCH101; eBioscience) and 
Ki-67 PE FITC (B56) was performed with 2 × 106 cells per tube according 
to manufacturers’ protocols. Absolute counting was performed using 50 µl 
whole blood in BD Trucount Tubes according to manufacturer’s protocol.
Microscopy.  Fluorescence  microscopy  was  performed  using  a TCS  SP2 
(Leica) confocal microscope with HCX Plan Apo ×40 NA 0.85 lens and 
PMTs running Leica LCS v2.61 software, or using an Axioplan 2 microscope 
(Carl Zeiss, Inc.) EC Plan-Neofluar ×40 NA 0.75 lens and Axiocam with 
running Axiovision v2.8 software (Carl Zeiss, Inc.). Separated epidermal sheets 
were fixed in acetone for 20 min and rehydrated in PBS for 15 min before 
staining. The following primary or directly labeled antibodies were used: anti-
CD1a FITC (NA1/34; Dako); anti–HLA-DR FITC (L243 or G46-6; BD); 
and anti–Ki-67 (rabbit monoclonal SP6; Vector Laboratories) followed by   
Alexafluor 555–conjugated goat anti–rabbit IgG (H+L; Invitrogen). Speci-
mens were mounted in VectaShield containing DAPI (Vector Laboratories).
ELISA. Serum Flt3L and SCF were measured by ELISA kits according to 
manufacturer’s instructions (Quantikine Human Flt3/Flk-2 Ligand Immuno-
assay and Quantikine Human SCF Immunoassay; R&D Systems).
Statistics. Graphs were plotted with Prism version 4 or 5 (GraphPad Soft-
ware Inc). Mean and SD calculation, paired Student’s t tests, and linear regres-
sion analysis were performed within the graphing software.
Online supplemental material. Fig. S1 shows the proliferative capacity 
of LCs and macrophages. Fig. S2 shows the Assessment of tissue macrophage 
populations in subject 3. Fig. S3 shows BM histology. Fig. S4 shows DC 
analysis after hematopoietic stem cell transplantation at 3 mo in subject 1 
and at 40 d in subject 3. Fig. S5 shows Q-PCR analysis of peripheral blood 
CD34+ cells from subjects 3 and 4 compared with healthy controls. Table S1 
shows a summary of clinical details. Table S2 shows automated peripheral 
blood count. Online supplemental material is available at http://www.jem 
.org/cgi/content/full/jem.20101459/DC1.
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important to exclude mutation of this gene as the cause of 
DCML deficiency. However, mRNA was detectable in sorted 
peripheral blood CD34+ cells by Q-PCR at 40.1% of normal 
(Fig. S5), and mutation of the Flt3 gene in germ-line DNA 
was excluded by sequencing. STAT3 and PU.1 mRNA were 
also detectable in peripheral blood CD34+ at 76.5 and 46.9% 
of normal, respectively. No mutation was detected in the PU.1 
gene. Interestingly, the expression of IRF8, a key regulator of 
DC differentiation, was substantially lower than controls (7.8%) 
and M-CSFR was undetectable (threshold 0.8%). These findings 
extend previous results obtained using granulocyte mRNA, 
and identify low IRF8 and M-CSFR expression as key com-
ponents of the molecular signature of DCML deficiency. We 
hypothesize that the defect must involve upstream regulators 
of these genes. Structural defects of IRF8 have been excluded 
by sequencing (unpublished data). Mutation of M-CSFR re-
mains a formal possibility, but is unlikely given that murine 
models primarily show defects of macrophage lineages and 
LCs with only minor DC deficiency (Ginhoux et al., 2009).
Murine KO mice with specific defects in DC development 
frequently show expanded progenitor compartments and in-
creased granulopoiesis, driven by elevated Flt3L (Schiavoni   
et al., 2002; Laouar et al., 2003; Birnberg et al., 2008). In con-
trast, we observed specific cellular defects in DCML deficiency 
with no proliferative response to Flt3L. This implies the exis-
tence of an early block in differentiation that prevents the ex-
pansion of progenitors by Flt3L, in addition to the disruption 
of committed DC, monocyte, and lymphoid lineages. Future 
studies aim to discover gene defects acting in this manner.
This report shows that DC deficiency is an integral part 
of the recently described syndrome of autosomal and sporadic 
monocytopenia for which we propose the alternative term 
DCML deficiency. DC depletion is almost universal in blood 
and skin, with the notable exception of epidermal LCs. We 
have shown that this syndrome is related to complete absence 
of MLP and depletion of GMP in the BM. In association 
with these cellular defects we found massively elevated Flt3L, 
supporting its role in vivo as a key “DC-poietin.” M-CSF was 
also increased. Finally, we provided correlative in vivo data of 
DC and T reg cell coregulation in humans, which is consis-
tent with a homeostatic model recently proposed in mice.
MATERIALS AND METHODS
Cell isolation and culture. Human peripheral blood, BM, and skin were 
obtained with informed consent and favorable ethical opinion from Newcastle 
and North Tyneside and North London Research Ethics Committees. Normal 
skin was obtained from mammoplasty surgery and 4-mm punch or shave 
skin biopsies were taken from subjects. Epidermal and dermal sheets were 
prepared by digestion with 1 mg/ml dispase (Invitrogen) and dermal sheets 
were treated with 0.8 mg/ml collagenase (Type IV; Worthington) as previously 
described (Haniffa et al., 2009). PBMCs and BM mononuclear cells were 
prepared by density-gradient centrifugation according to standard protocols.
IFN- and IL-12 production in vitro. Whole blood was diluted 1:5 with 
Rosewell Park Memorial Institute medium (RPMI) into 96-well F plates 
(Corning) and stimulated with IL-12 (20 ng/ml; R&D Systems; Abingdon), 
phytohemagglutinin (PHA; 10 µg/ml; Sigma-Aldrich), bacillus Calmette-Guerin 
(106/well; Statens Serum Institut, Copenhagen, Denmark), and LPS (1 µg/ml; 234 Human DC deficiency | Bigley et al.
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